Venlafaxine Hydrochloride
Product Images NDC 45865-864

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Venlafaxine Hydrochloride (NDC 45865-864). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Medsource Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

00093738656

Venlafaxine Hydrochloride capsule in bright orange with imprint '93 7386' on one side. The capsule is shown from two views, displaying the imprint on one side and plain orange surface on the opposite side. The image includes a measurement scale in millimeters for size reference.*

FDA Label Image

Pdp (864)

Venlafaxine Hydrochloride Extended Release (ER) Capsules 150 mg label, generic for Effexor XR, from medsource pharmaceuticals. The label includes medication instructions, warnings about dizziness, drowsiness, and alcohol use, plus packaging and lot information. It indicates a quantity of 30 capsules.*

FDA Label Image

Figure 1 (Venlafaxine HCl Er Caps A076565 1)

A pharmacokinetic (PK) fold change chart showing the effect of various interacting drugs on venlafaxine and its metabolite ODV. It includes data on Cmax and AUC changes with drugs such as ethanol, diazepam, cimetidine, ketoconazole, indinavir, metoprolol, imipramine, and lithium. Recommendations regarding dose adjustments or cautionary use are noted beside each interacting drug.*

FDA Label Image

Figure 2 (Venlafaxine HCl Er Caps A076565 2)

A forest plot chart showing pharmacokinetic fold changes (Cmax and AUC) for various interacting drugs with Venlafaxine Hydrochloride. The x-axis represents change relative to the reference value. Drugs listed include ethanol, diazepam, alprazolam, indinavir, metoprolol, risperidone, imipramine, haloperidol, caffeine, tolbutamide, and lithium, along with their analytes. The chart includes 90% confidence intervals and corresponding clinical recommendations such as dose adjustments or use caution guidance.*

FDA Label Image

Figure 3 (Venlafaxine HCl Er Caps A076565 3)

A scatter plot chart showing fold changes and 90% confidence intervals for venlafaxine and its analytes Cmax and AUC across special populations including hepatic impairment (cirrhosis, mild, moderate), renal impairment (mild/moderate, hemodialysis), CYP2D6 polymorphism, age over 60, and gender differences. Recommendations for dose adjustments are listed alongside each population group.*

FDA Label Image

Structural Formula For Venlafaxine Hydrochloride (Venlafaxine HCl Er Caps A076565 4)

Chemical structure of venlafaxine hydrochloride, depicting the molecular arrangement including a cyclohexane ring, methoxy group, and a dimethylamino functional group, labeled with the compound name beneath the structure.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.